Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.19% | $3.62M | €358.72B | 39.25% | 76 Outperform | |
| AstraZeneca | 2.06% | $2.34M | £213.94B | 27.90% | 78 Outperform | |
| Roche Holding AG | 2.03% | $2.31M | CHF250.59B | 35.86% | 73 Outperform | |
| Nestlé SA | 1.90% | $2.15M | CHF199.66B | 12.93% | 71 Outperform | |
| SAP SE | 1.88% | $2.13M | €242.59B | -10.16% | 66 Neutral | |
| HSBC Holdings | 1.87% | $2.12M | HK$1.92T | 46.27% | 79 Outperform | |
| Novartis AG | 1.82% | $2.07M | CHF202.12B | 14.17% | 80 Outperform | |
| Shell (UK) | 1.64% | $1.86M | £159.60B | 9.10% | 74 Outperform | |
| Siemens | 1.45% | $1.65M | €178.02B | 20.07% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.43% | $1.63M | €316.25B | 3.83% | 78 Outperform |